Dudediligence.

NeoGenomics, Inc

NEONASDAQ · Services-Testing Laboratories
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$4,143,321

4 notices · 267,490 sh

Apr 28 to Oct 4

Reported ·

$695,596

5 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

All 5 reported sales carry the 10b5-1 box. Together they are 0.05% of the shares on issue.

PLANNED · FORM 144Apr 28 to Oct 4REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-04: GREG AUNAN, Form 1442026-07-30: JEFFREY SHERMAN, Form 1442026-06-15: LYNN TETRAULT, Form 1442026-06-09: LYNN TETRAULT, Form 1442025-10-16: Olivo Alicia C, sold2025-11-25: Olivo Alicia C, sold2026-01-20: Stone Warren, sold2026-06-09: TETRAULT LYNN A., sold2026-06-15: TETRAULT LYNN A., sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-04GREG AUNAN, Chief Accounting Officer$321,480
20,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-30JEFFREY SHERMAN, Chief Financial Officer$3,704,556
236,876 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-15LYNN TETRAULT, Director$59,173
5,307 shplan 2026-03-10144 ↗
Form 4, 2026-06-17: sold 5,307 at $11.10 Form 4 ↗
2026-06-09LYNN TETRAULT, Director$58,112
5,307 shplan 2026-03-10144 ↗
Form 4, 2026-06-11: sold 5,307 at $11.29 Form 4 ↗